Milestones

February 2025

Selected as a 2024 Suzhou Potential Unicorn Enterprise with a valuation reaching $100 million

ꂂ

May 2024

Hepa Thera secured a spot on VBEF's 'Top 100 Most Innovative Healthcare Products' list.

ꂂ

July 2023

Hepa Thera Honored with Jiangsu Private Sci-Tech Enterprise Title

ꂂ

February 2023

Hepa Thera Secures 100M+ Yuan in Pre-A Round Financing

ꂂ

November 2021

Hepa Thera launches with successful seed round financing

ꂂ

May 2021

Hepa Thera is officially established

ꂂ

History Of Financing

The company was hatched by the Rehabilitation Capital New Drug Fund, and has completed more than RMB 200 million in seed, angel, Pre-A and A financing.